Sacroiliitis | Active disease at the last follow up | |||
---|---|---|---|---|
Odds Ratio (CI 95%) | p | Odds Ratio (CI 95%) | p | |
Univariate analysis | ||||
Boys | 0.7 (0.3–1.6) | 0.41 | 0.3 (0.1–0.7) | 0.01 |
HLA-B27 | 0.8 (0.3–1.9) | 0.67 | 0.9 (0.4–2.1) | 0.84 |
Age > 12 years | 1.7 (0.6–4.9) | 0.31 | 0.4 (0.1–1.1) | 0.07 |
Familial history of SpA | 3.6 (1.6–8.2) | 0.02 | 3.1 (1.4–7.1) | 0.01 |
Oligo-articular involvement at first consultation | 0.5 (0.2–1.0) | 0.06 | 0.5 (0.2–1.0) | 0.06 |
Hip Arthritis | 1.2 (0.6–2.5) | 0.66 | 1.4 (0.7–2.9) | 0.39 |
Enthesitis | 4.7 (1.3–17.5) | 0.01 | 1.7 (0.6–4.5) | 0.32 |
Extra-articular involvement | 1.2 (0.5–2.6) | 0.69 | 1 (0.5–2.2) | 1 |
Multivariable analysis | ||||
Boys | 0.94 (0.4–2.3) | 0.82 | 0.44 (0.2–1.1) | 0.06 |
Age > 12 years | 2.61 (08–8.8) | 0.09 | 0.48 (0.1–1.6) | 0.22 |
Familial history of SpA | 3.61 (1.5–8.7) | < 0.01 | 2.98 (1.2–7.3) | 0,02 |
Enthesitis | 4.2 (1.1–16.6) | 0.04 | 1.55 (0.5–4.9) | 0.45 |
Oligo-articular involvement at first consultation | 0.47 (0.2–1.2) | 0.10 | 0.73 (0.3–1.7) | 0.46 |